Dr. Slatko’s career experience includes three prior CMO executive roles over a 15 year period with a biopharmaceutical consulting firm, a specialty pharmaceutical company and a medical device start-up firm. For over six years, he served as a drug safety regulator at the U.S. Food and Drug Administration as a director in the Office of Medication Error Prevention and Risk Management. Earlier in his career, Dr. Slatko held various drug safety, clinical program, new product planning, medical affairs, managed care and executive leadership positions at Squibb, DuPont Merck, AstraZeneca, and GlaxoSmithKline. Dr. Slatko received a B.A. from Emory University, an M.D. from the University of Miami School of Medicine, and an M.B.A. from West Chester University. He is Board certified in Internal Medicine.